• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体内注射贝伐单抗(阿瓦斯汀)后由路邓葡萄球菌引起的急性眼内炎。

Acute endophthalmitis caused by Staphylococcus lugdunesis after intravitreal bevacizumab (Avastin) injection.

作者信息

Alkuraya Hisham S, Al-Kharashi Abdullah S, Alharthi Essam, Chaudhry Imtiaz A

机构信息

King Khalid Eye Specialist Hospital, Riyadh, Saudi Arabia.

出版信息

Int Ophthalmol. 2009 Oct;29(5):411-3. doi: 10.1007/s10792-008-9237-z. Epub 2008 Jun 5.

DOI:10.1007/s10792-008-9237-z
PMID:18528639
Abstract

PURPOSE

To report a case of culture-positive endophthalmitis after intravitreal injection of bevacizumab (Avastin) resulting in a devastating visual outcome.

METHOD

A retrospective case report of a 51-year-old diabetic women who presented with further decrease in her vision, redness, and mild pain in her eye 3 days after intravitreal injection of Avastin for macular edema due to a branch retinal vein occlusion.

RESULTS

Clinical diagnosis of endophthalmitis was made and, after obtaining a vitreous tap, intravitreal antibiotics were administered. Because of worsening of the endophthalmitis, pars plana vitrectomy was undertaken followed by repeat intravitreal antibiotics injection. The patient's ocular condition improved dramatically; however, her visual acuity did not improve. The cultures from vitreous taps revealed Staphylococcus lugdunesis.

CONCLUSION

Intravitreal injection of Avastin may be associated with a risk of S. lugdunesis-caused endophthalmitis which can have a devastating effect on the final visual outcome.

摘要

目的

报告1例玻璃体内注射贝伐单抗(阿瓦斯汀)后发生培养阳性的眼内炎,导致视力严重受损的病例。

方法

对1例51岁糖尿病女性患者进行回顾性病例报告。该患者因视网膜分支静脉阻塞导致黄斑水肿,在玻璃体内注射阿瓦斯汀3天后出现视力进一步下降、眼红和轻度眼痛。

结果

作出眼内炎的临床诊断,在进行玻璃体穿刺后,给予玻璃体内注射抗生素。由于眼内炎恶化,进行了玻璃体切割术,随后再次进行玻璃体内抗生素注射。患者的眼部状况显著改善;然而,其视力并未提高。玻璃体穿刺培养结果显示为路邓葡萄球菌。

结论

玻璃体内注射阿瓦斯汀可能与路邓葡萄球菌引起的眼内炎风险相关,这可能对最终视力结果产生严重影响。

相似文献

1
Acute endophthalmitis caused by Staphylococcus lugdunesis after intravitreal bevacizumab (Avastin) injection.玻璃体内注射贝伐单抗(阿瓦斯汀)后由路邓葡萄球菌引起的急性眼内炎。
Int Ophthalmol. 2009 Oct;29(5):411-3. doi: 10.1007/s10792-008-9237-z. Epub 2008 Jun 5.
2
Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗伴有灌注性视网膜静脉阻塞的黄斑水肿。
J Ocul Pharmacol Ther. 2010 Feb;26(1):85-90. doi: 10.1089/jop.2009.0090.
3
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗视网膜中央静脉阻塞所致黄斑水肿的短期研究。
Retina. 2006 Mar;26(3):279-84. doi: 10.1097/00006982-200603000-00005.
4
Acute bilateral endophthalmitis following bilateral intravitreal bevacizumab (avastin) injection.双眼玻璃体内注射贝伐单抗(阿瓦斯汀)后发生急性双侧眼内炎。
Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):87-8. doi: 10.4103/0974-9233.106402.
5
Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch.单次批次贝伐单抗玻璃体内注射后引发的无菌性眼内炎。
Retina. 2010 Mar;30(3):485-90. doi: 10.1097/IAE.0b013e3181bd2d51.
6
Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor.眼内抗血管内皮生长因子注射后眼内炎的临床特征。
Retina. 2010 Jul-Aug;30(7):1051-7. doi: 10.1097/IAE.0b013e3181cd47ed.
7
Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection.玻璃体内注射贝伐单抗(阿瓦斯汀)后急性发作性眼内炎的发生率。
Retina. 2008 Apr;28(4):564-7. doi: 10.1097/IAE.0b013e3181633fee.
8
Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection.玻璃体内注射贝伐单抗(阿瓦斯汀)后急性眼内炎的发生率和处理。
Eye (Lond). 2009 Dec;23(12):2187-93. doi: 10.1038/eye.2009.7.
9
Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.玻璃体培养指导下内眼注药后眼内炎治疗策略的改变
Am J Ophthalmol. 2019 Nov;207:224-231. doi: 10.1016/j.ajo.2019.06.008. Epub 2019 Jun 13.
10
Histopathology of streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients.玻璃体腔内注射贝伐单抗后口腔链球菌/咽峡链球菌性眼内炎的组织病理学:7 例报告。
Ophthalmology. 2014 Mar;121(3):702-8. doi: 10.1016/j.ophtha.2013.10.015. Epub 2014 Jan 16.

引用本文的文献

1
Timing of vitrectomy for treatment of endophthalmitis after intravitreal anti-VEGF injection: a systematic literature review of case reports and series.玻璃体内注射抗VEGF药物后发生眼内炎行玻璃体切割术的时机:病例报告及系列病例的系统文献综述
Ther Adv Ophthalmol. 2025 Jan 16;17:25158414241311064. doi: 10.1177/25158414241311064. eCollection 2025 Jan-Dec.
2
Treatment of myopic choroidal neovascularization with posterior sub-Tenon's bevacizumab injection (Avastin ®).经后Tenon囊下注射贝伐单抗(阿瓦斯汀®)治疗近视性脉络膜新生血管。
Int Ophthalmol. 2014 Aug;34(4):971-7. doi: 10.1007/s10792-014-9907-y. Epub 2014 Feb 2.
3

本文引用的文献

1
Infectious and noninfectious endophthalmitis after intravitreal bevacizumab.玻璃体内注射贝伐单抗后的感染性和非感染性眼内炎。
J Ocul Pharmacol Ther. 2007 Jun;23(3):240-2. doi: 10.1089/jop.2006.0146.
2
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗视网膜分支静脉阻塞继发的黄斑水肿。
Retina. 2007 Apr-May;27(4):419-25. doi: 10.1097/IAE.0b013e318030e77e.
3
Acute postoperative endophthalmitis caused by Staphylococcus lugdunensis.由路邓葡萄球菌引起的急性术后眼内炎。
Predicting visual outcomes for macular disease using optical coherence tomography.
使用光学相干断层扫描预测黄斑疾病的视觉预后。
Saudi J Ophthalmol. 2011 Apr;25(2):145-58. doi: 10.1016/j.sjopt.2011.01.003. Epub 2011 Jan 26.
4
Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?贝伐单抗用于治疗年龄相关性黄斑变性的超说明书用药:证据是什么?
Drugs Aging. 2009;26(4):295-320. doi: 10.2165/00002512-200926040-00002.
J Clin Microbiol. 2007 Jun;45(6):1673-8. doi: 10.1128/JCM.02499-06. Epub 2007 Mar 28.
4
Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection.玻璃体内注射贝伐单抗(阿瓦斯汀)后发生的急性眼内炎。
Eye (Lond). 2007 Mar;21(3):408-9. doi: 10.1038/sj.eye.6702683. Epub 2007 Feb 2.
5
The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.国际玻璃体腔内注射贝伐单抗安全性调查:利用互联网评估全球药物安全性。
Br J Ophthalmol. 2006 Nov;90(11):1344-9. doi: 10.1136/bjo.2006.099598. Epub 2006 Jul 19.
6
[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion].贝伐单抗治疗视网膜静脉阻塞继发的黄斑水肿
Ophthalmologe. 2006 Jun;103(6):471-5. doi: 10.1007/s00347-006-1355-2.
7
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗视网膜中央静脉阻塞所致黄斑水肿的短期研究。
Retina. 2006 Mar;26(3):279-84. doi: 10.1097/00006982-200603000-00005.
8
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗视网膜中央静脉阻塞所致黄斑水肿后的光学相干断层扫描结果
Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):336-9.
9
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.贝伐单抗(一种用于治疗癌症的抗血管内皮生长因子抗体)的发现与研发。
Nat Rev Drug Discov. 2004 May;3(5):391-400. doi: 10.1038/nrd1381.